Harbourvest Partners LLC Rhythm Pharmaceuticals, Inc. Transaction History

Harbourvest Partners LLC

  • $184 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$16.88 - $34.24 $95,186 - $193,079
5,639 New
5,639 $100,000
Q2 2020

Aug 13, 2020
SELL
$14.41 - $25.35 $723,684 - $1.27 Million
-50,221 Closed
0 $0
Q1 2019

May 13, 2019
BUY
$24.76 - $31.66 $1.24 Million - $1.59 Million
50,221 New
50,221 $1.38 Million

Others Institutions Holding RYTM

# of Institutions
178
Shares Held
69.1M
Call Options Held
467K
Put Options Held
224K
View Full List

About RHYTHM PHARMACEUTICALS, INC.

RYTM Quotes by TradingView
  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $2.86B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Harbourvest Partners LLC Portfolio

Follow Harbourvest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbourvest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbourvest Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email